S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Laser breakthrough could send stock soaring 2,467% (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Laser breakthrough could send stock soaring 2,467% (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Laser breakthrough could send stock soaring 2,467% (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
Laser breakthrough could send stock soaring 2,467% (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
NYSE:COO

Cooper Companies (COO) Price Target & Analyst Ratings

$353.55
-2.92 (-0.82%)
(As of 06/5/2023 ET)
Compare
Today's Range
$353.01
$359.84
50-Day Range
$353.55
$392.09
52-Week Range
$244.21
$395.20
Volume
296,300 shs
Average Volume
302,942 shs
Market Capitalization
$17.49 billion
P/E Ratio
60.96
Dividend Yield
0.02%
Price Target
$393.89

Cooper Companies Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 7 Analyst Ratings

Consensus Analyst Price Target

$393.89
11.41% Upside
High Prediction$430.00
Average Prediction$393.89
Low Prediction$295.00
TypeCurrent
6/6/22 to 6/6/23
1 Month Ago
5/7/22 to 5/7/23
3 Months Ago
3/8/22 to 3/8/23
1 Year Ago
6/6/21 to 6/6/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
8 Buy rating(s)
Hold
2 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$393.89$389.80$382.60$432.89
Predicted Upside11.41% Upside17.83% Upside19.08% Upside15.42% Upside
Get Cooper Companies Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.


COO Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

COO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cooper Companies Stock vs. The Competition

TypeCooper CompaniesMedical CompaniesS&P 500
Consensus Rating Score
2.71
2.66
2.48
Consensus RatingModerate BuyBuyHold
Predicted Upside11.41% Upside1,271.39% Upside219.76% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/2/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$385.00 ➝ $400.00+6.89%
5/30/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageEqual Weight$410.00+10.99%
5/24/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$375.00 ➝ $430.00+14.42%
5/16/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$380.00 ➝ $420.00+7.87%
5/15/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$355.00 ➝ $430.00+10.21%
4/18/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$390.00 ➝ $400.00+7.68%
4/3/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$372.00 ➝ $430.00+15.17%
11/28/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$300.00 ➝ $330.00+4.97%
10/11/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$400.00 ➝ $295.00+15.09%
(Data available from 6/6/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












COO Price Target - Frequently Asked Questions

What is Cooper Companies's consensus rating and price target?

According to the issued ratings of 7 analysts in the last year, the consensus rating for Cooper Companies stock is Moderate Buy based on the current 2 hold ratings and 5 buy ratings for COO. The average twelve-month price prediction for Cooper Companies is $393.89 with a high price target of $430.00 and a low price target of $295.00. Learn more on COO's analyst rating history.

Do Wall Street analysts like Cooper Companies more than its competitors?

Analysts like Cooper Companies more than other Medical companies. The consensus rating for Cooper Companies is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how COO compares to other companies.

Does Cooper Companies's stock price have much upside?

According to analysts, Cooper Companies's stock has a predicted upside of 14.37% based on their 12-month price targets.

What analysts cover Cooper Companies?

Cooper Companies has been rated by Citigroup, Mizuho, Morgan Stanley, Piper Sandler, Robert W. Baird, Stifel Nicolaus, and Wells Fargo & Company in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:COO) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -